News
Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.
President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...
President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in negotiations ahead of an Aug. 1 deadline for sweeping duties to take effect.
President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...
As Washington presses ahead with additional tariffs on products from the European Union (EU) and beyond, European officials ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
The United States recent tariff announcements have cut down forecast for Southeast Asian economies, with the more ...
Bank of Ireland has revised upwards its economic forecasts for the year - if US tariffs remain at 10%. It predicts GDP growth of 8.1%, higher than the 3.5% growth previously forecast. The bank says ...
Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results